Difenoximide hydrochloride

Dibucaine hydrochloride is a quinolone derivative, which can be prepared using isatin as the starting material followed by a series of reactions. It is a local anesthetic agent.

Application Diclofenac sodium has been used: to investigate its radioprotective potential in a study to determine the basic viscosity and hydrodynamic values of the solubilizers and their micellar adducts in a study as a standard for potentiometric

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Diethylmalonyl dichloride has been used in the preparation of: 5,5-diethyl-1,3-dihydroxybarbituric acid ( N,N&#8242 -dihydroxyveronal) via condensation with 1,3-dibenzyloxyurea 1,11-dibronzo-4,8-diaza-6,6-diethyl-5,7-dioxoundecane

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

A peripheral dopamine D2 and D3 receptor antagonist (Ki = 0.3 nM IC₅₀ = 13.

A peripheral dopamine D2 and D3 receptor antagonist (Ki = 0.3 nM IC₅₀ = 13.

A peripheral dopamine D2 and D3 receptor antagonist (Ki = 0.3 nM IC₅₀ = 13.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the